Pharmaleaders 2014 Leadership Summit to debate “Make In India” & Healthcare Reforms!

Decision-makers, Opinion Leaders & Pharmaleaders to meet to discuss consequences of actions and of non-actions to accelerate Healthcare Reforms at 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014
 
 
Pharma Leaders
Pharma Leaders
MUMBAI, India - Oct. 27, 2014 - PRLog -- Pharmaleaders 2014 Leadership Summit to debate “Make In India” & Healthcare Reforms!

Decision-makers, Opinion Leaders & Pharmaleaders to meet to discuss consequences of actions and of non-actions to accelerate Healthcare Reforms at 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014

Monday, 26th October 2014, Mumbai, Maharashtra: At a time when the new government at the centre led by BJP led Modi Government  is busy trying to repair existing potholes, fix areas of concerns , repeal unnecessary & cumbersome laws to bring meaningful reforms to infuse confidence & trust in the minds of the investors, all is not well in the pharmaceutical & healthcare sector. While the previous & predecessor regimes repeatedly failed to effect a new change of policy to bring far reaching changes in the highly sensitive & knowledge based industry, the present regime will have to work hard to make India preferred destination of investments in medical devices, pharmaceutical manufacturing & healthcare innovations. Keeping the mantra of “Make In India” campaign, Pharmaleaders , India’s most analytical news media in healthcare communications is hosting the much awaited & widely acclaimed annual event, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014 in a uniquely positioned full day program encompassing two themes “Make In India – Healthcare Reforms , Insurance,Innovations,Investments & Infrastructure” & Empowering India’s Developing Healthcare System - Investing the Healthcare Solutions of Tomorrow in difficult Times at on December. 26, 2014 at the Sahara Star, Mumbai International Airport in Mumbai, India.

Pharmaleaders believe that much need to be done to accomplish the super success in the pharmaceutical industry & a series of steps need to be initiated to expel the confusion that prevail amongst the investors & manufacturers. Industry experts believe that Prime Minister Modi has the oppourtunity to turn the table forward & make india proud as she says  “Make in India” is a great slogan but can we back it with enabling policies?Manufacturing calls for low cost capital, speed of project implementation, operational efficiency and global competitiveness. Prime Minister Modi’s 3D campaign for Democracy, Demography and Demand revolves around the principles of free enterprise, demographic dividend and market demand. However, in reality, none of these are easy to achieve in India. Over regulation and nepotism have crippled free enterprise, poor education has resulted in a skill deficit and sub-optimal logistics and inadequate infrastructure has stifled demand. We have to add to this the cumbersome and difficult land acquisition and labour laws that challenge the credibility of “Make in India”. A “Made in India” label has a huge credibility challenge in terms of quality, consistency and dependability. We need urgent regulatory and policy reforms that are aligned with what “Make in India” should stand for: Highest Quality at Lowest Cost. A combination of self-certification and third party audits can provide a quick start to address speed and quality. Special Economic Zones (SEZs) need to be revived and revitalized as they are neither “Special” nor “Economic”! We have 478 approved SEZs of which only 172 are operational. Simplification of operational norms through self-certification, removal of the Minimum Alternate Tax (MAT) and Dividend Distribution Tax (DDT) and perhaps exempting Domestic Tariff Area (DTA) sales from duties will energize this ailing sector. It is worth noting that the 172 SEZs that are operational, account for 25% of manufacturing exports.

If India is to build a credible scientific and engineering profile, then we do need to seriously invest in research in the public and private sectors. India’s Space Research budget was a modest $1.3 Billion for FY15 compared to NASA’s $16.6 Billion. Despite this frugal investment, ISRO has had a number of successful space programs crowned by the Mars Orbiter Mission. Behind its success is a vibrant multi-disciplinary scientific and engineering talent pool. Mangalyaan is a powerful mascot for Indian Science and Technology. Scaling up ISRO will provide exciting opportunities to Physicists, Mathematicians, Computer Scientists,
Drug discovery has always been an area that has eluded us despite our scientific and medical talent pool. We have preferred to export our talent than provide them with a research platform in our country. Our doctors have preferred to be medical practitioners than clinical researchers. Our pharmaceutical companies have preferred to imitate and produce generic drugs rather than innovate and develop novel drugs. All this has led to a risk-averse eco-system in bio-medical research which has seen a ban on clinical trials, a hesitant regulatory system that does not have confidence in approving new drugs and above all, a medical community who trust foreign rather than home grown innovation. Moreover, we have barely created any Intellectual Property that could add credible value to our scientific pursuits. Unless we change this, we will not leverage the rich talent pool that we have and we will lose an opportunity to lead in an area so critical to our people who deserve access to affordable and innovative therapeutics.

Pharmaleaders attempt is  to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”.


"Pharmaleaders Power Brand Awards are the most prestigious annual industry awards recognized annually that acknowledge and honor individuals and organizations for their accomplishments using healthcare innovations  to deliver the best value in achieving specific goals and objectives," said Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group  . These are fitting tribute  to those individuals and companies that have gone the extra mile to advance the excellence in healthcare  through best practices and leadership.

Contact
Network 7 Media Group
***@network7mediagroup.com
End
Source: » Follow
Email:***@network7mediagroup.com Email Verified
Tags:Pharmaleaders, Pharma Summit, Health, Indian Pharma
Industry:Biotech, Health
Location:Mumbai - Maharashtra - India
Subject:Features
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Network7mediagroup PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share